Fortuno, C., Mester, J., Pesaran, T., Weitzel, J. N., Dolinsky, J., Yussuf, A., . . . Spurdle, A. B. (2020). Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines. Hum Mutat.
Stile di citazione ChicagoFortuno, Cristina, et al. "Suggested Application of HER2+ Breast Tumor Phenotype for Germline TP53 Variant Classification Within ACMG/AMP Guidelines." Hum Mutat 2020.
Citazione MLAFortuno, Cristina, et al. "Suggested Application of HER2+ Breast Tumor Phenotype for Germline TP53 Variant Classification Within ACMG/AMP Guidelines." Hum Mutat 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.